38
Table 8-3 IEC EMC Specications (Immunity)
Guidance and Manufacturer’s Declaration – Electromagnetic Immunity
The HALYARD* Pain Management System is intended for use in the electromagnetic environment specied below. The customer or the user of the HALYARD* Pain
Management System should assure that it is used in such an environment.
Immunity test IEC 60601 test level Compliance level Electromagnetic environment - guidance
Electrostatic discharge (ESD)
IEC 61000-4-2
±6 kV contact
±8 kV air
±6 kV contact
±8 kV air
Floors should be wood, concrete or ceramic tile. If oors are covered with
synthetic material, the relative humidity should be at least 30%.
Electrical fast transient/burst
IEC 61000-4-4
±2 kV for power supply lines
±1 kV for input/output lines
±2 kV for power supply lines
±1 kV for input/output lines
Mains power quality should be that of a typical commercial or hospital
environment.
Surge
IEC 61000-4-5
±1 kV dierential mode
±2 kV common mode
±1 kV dierential mode
±2 kV common mode
Mains power quality should be that of a typical commercial or hospital
environment.
Voltage dips, short
interruptions and voltage
variations on power supply
input lines
IEC 61000-4-11
<5% U
T
(>95% dip in U
T
)
for 0.5 cycles
40% U
T
(60% dip in U
T
)
for 5 cycles
70% U
T
(30% dip in U
T
)
for 25 cycles
<5% U
T
(>95% dip in U
T
) for
5 seconds
<5% U
T
(>95% dip in U
T
)
for 0.5 cycles
40% U
T
(60% dip in U
T
)
for 5 cycles
70% U
T
(30% dip in U
T
)
for 25 cycles
<5% U
T
(>95% dip in U
T
)
for 5 seconds
Mains power quality should be that of a typical commercial or hospital
environment. If the user of the HALYARD* Pain Management System requires
continued operation during power mains interruptions, it is recommended
that the HALYARD* Pain Management System be powered from an
uninterruptible power supply or battery.
Power frequency (50/60 Hz)
magnetic eld
IEC 61000-4-8
3 A/m 3 A/m Power frequency magnetic elds should be at levels characteristic of typical
location in a typical commercial or hospital environment.
NOTE: U
T
is the AC mains voltage prior to application of the test level.
Conducted RF IEC
61000-4-6
Radiated RF IEC
61000-4-3
3 V
rms
150 kHz to 80 MHz
3 V/m
80 MHz to 2.5 GHz
3 V
rms
3 V/m
Portable and mobile RF communications equipment should be used no closer
to any part of the HALYARD* Pain Management System including cables,
than the recommended separation distance calculated from the equation
applicable to the frequency of the transmitter.
Recommended separation distance:
d = [1.17] √P
d = [1.17] √P 80 MHz to 800 MHz
d = [2.33] √P 800 MHz to 2.5 GHz
where P is the maximum output power rating of the transmitter in watts
(W) according to the transmitter manufacturer and d is the recommended
separation distance in meters (m).
Field strengths from xed RF transmitters, as determined by an
electromagnetic site survey,
a
should be less than the compliance level in each
frequency range
b
.
Interference may occur in the vicinity of equipment marked with the following
symbol:
NOTE 1: At 80 MHz and 800 MHz, the higher frequency range applies.
NOTE 2: These guidelines may not apply in all situations. Electromagnetic propagation is aected by absorption and reection from structures, objects and people.
a
Field strengths from xed transmitters, such as base stations for radio (cellular/cordless) telephones and land mobile radios, amateur radio, AM and FM radio broadcast and
TV broadcast cannot be predicted theoretically with accuracy. To assess the electromagnetic environment due to xed RF transmitters, an electromagnetic site survey should
be considered. If the measured eld strength in the location in which the HALYARD* Pain Management System or any of its components are used exceeds the applicable RF
compliance level above, the HALYARD* Pain Management System should be observed to verify normal operation. If abnormal performance is observed, additional measures
may be necessary, such as reorienting or relocating components or the entire HALYARD* Pain Management System.
b
Over the frequency range 150 kHz to 80 MHz, eld strengths should be less than 3 V/m.
Avanos Exhibit 2069 Page 38
Medtronic, Inc. v. Avanos Medical Sales, LLC
Case IPR2020-0089